Personalized Medicine Requires Personalized Measurement

February 23, 2018

The Otsuka and Noven successes from 2018 portend a new era of drug development, one in which treatment efficacy is established in the context of the patient's overall life and behavior. It is time for measurement science to follow and embrace the fact that how we measure outcomes will evolve from applying one solution to finding an empirical basis for a highly customized application of all of them, enabled by technology. Personalized medicine needs a more personalized approach to measurement. 

Previous Flipbook
Rare Disease Case Study: Familial Amyloidosis
Rare Disease Case Study: Familial Amyloidosis

Our client, a top-tier CRO, was faced with the challenge of enrolling for a non-interventional screening st...

Next Flipbook
Looking Ahead in 2018: Insights into Clinical Research Trends from Our Experts
Looking Ahead in 2018: Insights into Clinical Research Trends from Our Experts

In this paper, WCG thought-leaders provide insights on what they anticipate in 2018 in clinical trial techn...